Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
Author:
Affiliation:
1. Center for Oncological Research Antwerp, Laboratory of Cancer Research and Clinical Oncology, University of Antwerp, Wilrijk, Belgium;
2. Department of Oncology, Antwerp University Hospital, Edegem, Belgium
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0013
Reference204 articles.
1. The molecular biology of head and neck cancer;Leemans;Nat Rev Cancer,2011
2. Dysregulated molecular networks in head and neck carcinogenesis;Molinolo;Oral Oncol,2009
3. Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and bcl-X (L) enhances antitumor effects in squamous cell carcinoma of the head and neck;Boehm;Mol Pharmacol,2008
4. Personalized medicine in oncology: The future is now;Schilsky;Nat Rev Drug Discov,2010
5. Cancer biomarkers: Selecting the right drug for the right patient;Kelloff;Nat Rev Drug Discov,2012
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer;Indian Journal of Otolaryngology and Head & Neck Surgery;2023-04-20
2. Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?;Cancers;2022-12-12
3. Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes;Clinical Cancer Research;2022-10-31
4. The prognostic impact of the immune signature in head and neck squamous cell carcinoma;Frontiers in Immunology;2022-10-04
5. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival;BMC Cancer;2022-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3